{"SPADE_N_14930": {"basic": {"SPADE ID": "SPADE_N_14930", "Peptide Name": "Bisebromoamide", "Sequence": "AXXCLXX", "Source": "1. Lyngbya sp.", "Biological Activity": ["Anticancer"], "Target Organism": "Human breast adenocarcinoma MCF-7(IC50=0.035µM),Human breast adenocarcinoma MDA-MB-231(IC50=0.038µM),Human breast carcinoma BSY-1(IC50=0.024µM),Human breast carcinoma HBC-4(IC50=0.097µM),Human glioblastoma U251-MG(IC50=0.034µM),Human Astrocytoma SF-268(IC50=0.038µM),Human Astrocytoma SF-539(IC50=0.028µM),Human brain cancer SNB-78(IC50=0.036µM),Human colon adenocarcinoma HT29(IC50=0.033µM),Human colon adenocarcinoma HCT-15(IC50=0.1µM),Human colon adenocarcinoma HCT 116(IC50=0.093µM),Human lung adenocarcinoma NCI-H23(IC50=0.092µM),Human lung adenocarcinoma NCI-H522(IC50=0.027µM),Human lung carcinoma NCI-H460(IC50=0.035µM),Human lung carcinoma A549(IC50=0.039µM),Human lung carcinoma DMS 273(IC50=0.037µM),Human melanoma LOX-IMVI(IC50=0.026µM),Human epithelial carcinoma OVCAR-3(IC50=0.028µM),Human epithelial carcinoma OVCAR-5(IC50=0.1µM),Human ovarian adenocarcinoma SK-OV-3(IC50=0.086µM),Human renal adenocarcinoma ACHN(IC50=0.032µM),Human gastric cancer MKN 45(IC50=0.037µM),Human gastric cancer MKN 28(IC50=0.047µM),Human gastric cancer MKN 7(IC50=0.013µM),Human prostate cancer DU145(IC50=0.061µM),Human prostate adenocarcinoma PC-3(IC50=0.1µM)", "Sequence Length": 7}, "extended_data_url": "SPADE_N_14930_extended.json"}}